Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016
by
Rea, Elizabeth
, Sabur, Natasha F.
, Chiang, Leslie Y.
, Oxlade, Olivia
, Schwartzman, Kevin
, Johnston, James C.
, Jamieson, Frances
, Sander, Beate
, Uppal, Aashna
, Brode, Sarah K.
, Khadawardi, Hadeel
, Mah, Henry K.-H.
, Campbell, Jonathon R.
, Romanowski, Kamila
, Nsengiyumva, Placide
, Rasberry, Hayden
in
Antimicrobial agents
/ antimicrobial resistance
/ Antitubercular Agents - therapeutic use
/ bacteria
/ bacterial infections
/ Canada - epidemiology
/ Care and treatment
/ cost assessment
/ Cost estimates
/ Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016
/ Decision making
/ Diagnostic tests
/ Drug resistance
/ Economic aspects
/ Health surveillance
/ Hospitalization
/ Humans
/ Infections
/ Isoniazid - therapeutic use
/ Latent Tuberculosis - drug therapy
/ Medical care, Cost of
/ Mycobacterium tuberculosis
/ Public health
/ respiratory infections
/ Retrospective Studies
/ Statistics
/ Tuberculosis
/ Tuberculosis - drug therapy
/ Tuberculosis - epidemiology
/ tuberculosis and other mycobacteria
/ Tuberculosis, Multidrug-Resistant - drug therapy
/ Tuberculosis, Multidrug-Resistant - epidemiology
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016
by
Rea, Elizabeth
, Sabur, Natasha F.
, Chiang, Leslie Y.
, Oxlade, Olivia
, Schwartzman, Kevin
, Johnston, James C.
, Jamieson, Frances
, Sander, Beate
, Uppal, Aashna
, Brode, Sarah K.
, Khadawardi, Hadeel
, Mah, Henry K.-H.
, Campbell, Jonathon R.
, Romanowski, Kamila
, Nsengiyumva, Placide
, Rasberry, Hayden
in
Antimicrobial agents
/ antimicrobial resistance
/ Antitubercular Agents - therapeutic use
/ bacteria
/ bacterial infections
/ Canada - epidemiology
/ Care and treatment
/ cost assessment
/ Cost estimates
/ Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016
/ Decision making
/ Diagnostic tests
/ Drug resistance
/ Economic aspects
/ Health surveillance
/ Hospitalization
/ Humans
/ Infections
/ Isoniazid - therapeutic use
/ Latent Tuberculosis - drug therapy
/ Medical care, Cost of
/ Mycobacterium tuberculosis
/ Public health
/ respiratory infections
/ Retrospective Studies
/ Statistics
/ Tuberculosis
/ Tuberculosis - drug therapy
/ Tuberculosis - epidemiology
/ tuberculosis and other mycobacteria
/ Tuberculosis, Multidrug-Resistant - drug therapy
/ Tuberculosis, Multidrug-Resistant - epidemiology
2022
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016
by
Rea, Elizabeth
, Sabur, Natasha F.
, Chiang, Leslie Y.
, Oxlade, Olivia
, Schwartzman, Kevin
, Johnston, James C.
, Jamieson, Frances
, Sander, Beate
, Uppal, Aashna
, Brode, Sarah K.
, Khadawardi, Hadeel
, Mah, Henry K.-H.
, Campbell, Jonathon R.
, Romanowski, Kamila
, Nsengiyumva, Placide
, Rasberry, Hayden
in
Antimicrobial agents
/ antimicrobial resistance
/ Antitubercular Agents - therapeutic use
/ bacteria
/ bacterial infections
/ Canada - epidemiology
/ Care and treatment
/ cost assessment
/ Cost estimates
/ Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016
/ Decision making
/ Diagnostic tests
/ Drug resistance
/ Economic aspects
/ Health surveillance
/ Hospitalization
/ Humans
/ Infections
/ Isoniazid - therapeutic use
/ Latent Tuberculosis - drug therapy
/ Medical care, Cost of
/ Mycobacterium tuberculosis
/ Public health
/ respiratory infections
/ Retrospective Studies
/ Statistics
/ Tuberculosis
/ Tuberculosis - drug therapy
/ Tuberculosis - epidemiology
/ tuberculosis and other mycobacteria
/ Tuberculosis, Multidrug-Resistant - drug therapy
/ Tuberculosis, Multidrug-Resistant - epidemiology
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016
Journal Article
Costs of Tuberculosis at 3 Treatment Centers, Canada, 2010–2016
2022
Request Book From Autostore
and Choose the Collection Method
Overview
We estimated costs of managing different forms of tuberculosis (TB) across Canada by conducting a retrospective chart review and cost assessment of patients treated for TB infection, drug-susceptible TB (DS TB), isoniazid-resistant TB, or multidrug-resistant TB (MDR TB) at 3 treatment centers. We included 90 patients each with TB infection and DS TB, 71 with isoniazid-resistant TB, and 62 with MDR TB. Median per-patient costs for TB infection (in 2020 Canadian dollars) were $804 (interquartile range [IQR] $587-$1,205), for DS TB $12,148 (IQR $4,388-$24,842), for isoniazid-resistant TB $19,319 (IQR $7,117-$41,318), and for MDR TB $119,014 (IQR $80,642-$164,015). Compared with costs for managing DS TB, costs were 11.1 (95% CI 9.1-14.3) times lower for TB infection, 1.7 (95% CI 1.3-2.1) times higher for isoniazid-resistant TB, and 8.1 (95% CI 6.1-10.6) times higher for MDR TB. Broadened TB infection treatment could avert high costs associated with managing TB disease.
Publisher
U.S. National Center for Infectious Diseases,Centers for Disease Control and Prevention
This website uses cookies to ensure you get the best experience on our website.